For research use only. Not for therapeutic Use.
SCH 18099（Cat No.:I009378）is a selective antagonist of the dopamine D3 receptor, a subtype of dopamine receptor that is implicated in several neuropsychiatric conditions, including schizophrenia, addiction, and mood disorders. By targeting the D3 receptor, SCH 18099 aims to modulate dopamine signaling, potentially reducing symptoms associated with these disorders. It has been explored as a potential treatment for substance use disorders and psychosis, as blocking D3 receptors may decrease the rewarding effects of drugs and help alleviate behavioral symptoms.
| Catalog Number | I009378 |
| CAS Number | 28953-25-5 |
| Synonyms | Sch 18099; Sch18099; Sch-18099.;Ethyl-6-ethoxybenzothiazole-2-carbamate |
| Molecular Formula | C12H14N2O3S |
| Purity | ≥95% |
| Solubility | Soluble in DMSO |
| Storage | 0 - 4 °C for short term, or -20 °C for long term |
| IUPAC Name | ethyl N-(6-ethoxy-1,3-benzothiazol-2-yl)carbamate |
| InChI | InChI=1S/C12H14N2O3S/c1-3-16-8-5-6-9-10(7-8)18-11(13-9)14-12(15)17-4-2/h5-7H,3-4H2,1-2H3,(H,13,14,15) |
| InChIKey | IOVKGYFVWSODCN-UHFFFAOYSA-N |
| SMILES | CCOC1=CC2=C(C=C1)N=C(S2)NC(=O)OCC |
